Claire Mazumdar, Director of Relay Therapeutics RLAY, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $3.5M. The latest trade was on 06/09.

Claire Mazumdar

Director

Company

Relay Therapeutics RLAY

First filing

25/06/11

Trades

51 trades

Buys / sales

0 / 14

12-month net buying

−$3.5M

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	05/18	05/20	15,000 sh2 trades	$20.04avg.	$300,561.42	−4.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	04/20	04/20	15,000 sh	$23.61	$354,150	−4.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/18–03/20	03/20	15,000 sh3 trades	$18.82avg.	$282,361.26	−4.2%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/09	03/11	36,766 sh	$19.17	$704,804.22	−9.8%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/04–03/06	03/06	8,234 sh3 trades	$18.74avg.	$154,317.02	−2.4%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/11/24	25/11/25	41,163 sh	$18.86	$776,334.18	−11.7%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/10/16	25/10/20	24,103 sh	$18.83	$453,859.49	−7.2%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/10/13–25/10/15	25/10/15	24,734 sh2 trades	$18.88avg.	$466,904.16	−7.4%